Vitamin K2
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 100% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
15 Drop(s)
Serving Size
80
Servings
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
15 mg
(12500% DV)
📊 125.0× RDA — above typical dose
📚 273 studies (Tier A: 9, B: 175)
Other Ingredients
Medium Chain Triglyceride Oil
Mixed Tocopherols
Label Claims — Verification
❓
All Other
All Other (100% of products)
Structure/Function (84% of products)
Nutrient (73% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested use: Take 15 drops one to three times daily or as recommended by your health-care practitioner. Invert bottle to dispense individual drops. May be added to food or mixed in beverages.
⚠️ Warnings & Precautions
Tamper evident: Use only if bottle is sealed.
If pregnant, consult your health-care practitioner before using this product.
Additional Information
Do not refrigerate.
Store tightly in a cool, dry place.
Product Details
Research Evidence
332
Research Sources
59
Avg Quality Score
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
A
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Compare Similar Products
Bio-K-Mulsion
Biotics Research Corporation
100
Super Daily K2 45 mcg
Carlson
100
Ultimate K2
Pure TheraPro Rx
100
Kid's Super Daily K2 22.5 mcg
Carlson
100
Liquid D-3 & MK-7
NOW
100